SARASOTA, Fla., July 10, 2018 /PRNewswire/ -- The Roskamp Institute is pleased to announce that its second annual seminar, Grey Matters—A Symposium on Alzheimer's Disease Research, is nearly sold out.
"We are thrilled with the outpouring of support for our Grey Matters event. The level of interest speaks to the fact that Alzheimer's impacts so many people in so many ways," said Roskamp Institute CEO Fiona Crawford, Ph.D.
Current research from the Alzheimer's Association found that one in nine people age 65 and older have Alzheimer's dementia. By 2050, it is estimated that as many as 16 million Americans will have Alzheimer's disease, with 135 million people affected worldwide—figures that do not take into account patients' loved ones and caretakers. The emotional and financial costs of the disease are staggering.
Speaker Andrew Keegan, M.D., Director of The Roskamp Institute Clinic and key leadership from The Institute will present on a variety of topics concerning brain health, including potential treatments, lifestyle choices that help prevent degeneration, early symptom warnings, and clinical research updates.
Funds raised from The Grey Matters Symposium provide direct monetary support to medical research currently conducted at The Roskamp Institute.
After establishing research facilities locally in 2003, the Roskamp Institute has made important discoveries with profound clinical implications for millions of Americans suffering from Alzheimer's disease and other debilitating neurological disorders.
The Institute has become firmly established as a leading not-for-profit, independent body in the international research community with its programs and projects supported by the National Institutes of Health, the U.S. Department of Defense, the Veterans Administration, the European Commission Seventh Framework Programme, and several other national and international peer-reviewed agencies.
For information on remaining sponsorships, please call Megan Micale at (941) 552-9832 or email [email protected].
ABOUT THE ROSKAMP INSTITUTEThe Roskamp Institute's mission is understanding causes and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. The Institute utilizes a broad range of highly advanced scientific approaches to understand the causes of, and potential therapies for, these disorders. From this work, novel treatments developed by the Roskamp Institute have been clinically tested in Europe and the U.S. If you wish to sponsor or learn more about our critical research, please visit www.roskampinstitute.org. To tour the laboratories and facilities, please call (941) 552-9832.
Advertisement
"We are thrilled with the outpouring of support for our Grey Matters event. The level of interest speaks to the fact that Alzheimer's impacts so many people in so many ways," said Roskamp Institute CEO Fiona Crawford, Ph.D.
Advertisement
Current research from the Alzheimer's Association found that one in nine people age 65 and older have Alzheimer's dementia. By 2050, it is estimated that as many as 16 million Americans will have Alzheimer's disease, with 135 million people affected worldwide—figures that do not take into account patients' loved ones and caretakers. The emotional and financial costs of the disease are staggering.
Speaker Andrew Keegan, M.D., Director of The Roskamp Institute Clinic and key leadership from The Institute will present on a variety of topics concerning brain health, including potential treatments, lifestyle choices that help prevent degeneration, early symptom warnings, and clinical research updates.
Funds raised from The Grey Matters Symposium provide direct monetary support to medical research currently conducted at The Roskamp Institute.
After establishing research facilities locally in 2003, the Roskamp Institute has made important discoveries with profound clinical implications for millions of Americans suffering from Alzheimer's disease and other debilitating neurological disorders.
The Institute has become firmly established as a leading not-for-profit, independent body in the international research community with its programs and projects supported by the National Institutes of Health, the U.S. Department of Defense, the Veterans Administration, the European Commission Seventh Framework Programme, and several other national and international peer-reviewed agencies.
For information on remaining sponsorships, please call Megan Micale at (941) 552-9832 or email [email protected].
ABOUT THE ROSKAMP INSTITUTEThe Roskamp Institute's mission is understanding causes and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. The Institute utilizes a broad range of highly advanced scientific approaches to understand the causes of, and potential therapies for, these disorders. From this work, novel treatments developed by the Roskamp Institute have been clinically tested in Europe and the U.S. If you wish to sponsor or learn more about our critical research, please visit www.roskampinstitute.org. To tour the laboratories and facilities, please call (941) 552-9832.
View original content:http://www.prnewswire.com/news-releases/just-a-few-tickets-remain-for-roskamp-institutes-grey-matters-symposium-on-alzheimers-disease-research-300678828.html
SOURCE Roskamp Institute
